WCN25-4287 TRANSPLANT OUTCOMES IN PATIENTS WITH PRIMARY FSGS: A SINGLE CENTRE EXPERIENCE

Recurrence of primary focal segmental glomerulosclerosis (pFSGS) in patients after kidney transplantation is variable with increased rates of graft loss. Risk factors of recurrence include young age, steroid resistant nephrotic syndrome at presentation and higher BMI at transplant. Plasma Exchange (PLEX), Rituximab and combination of both are commonly used treatment strategies. In this study, we report the course and post transplant outcomes in patients with pFSGS as basic disease.